IL17A and systemic sclerosis: MiRNA-21a-5p inhibition through plasmid containing of anti-miRNA-21a-5p treatment lowered the infiltration of cells secreting TNF-α, IL-β, IL-6, or IL-17 in the lesional skin tissue of SSc mice (Fig. 5).